Skip to content
Trend Global Media

The Zimbabwean Government Turns Down ‘One-Sided’ American Health Aid Agreement Due to Information Apprehensions

Medical aid image
The offered US funding would have supported initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has rejected a major American healthcare agreement valued at $367m (£272m) over five years because of Washington's request for confidential data.

The decision was revealed following a government memo from December was disclosed, which showed President Emmerson Mnangagwa felt the arrangement was "lopsided".

A government spokesman has since stated that the US was demanding access to genetic material for scientific study and commercial gain while was unwilling to share the benefits from future vaccines.

"We are forced to start the difficult and regrettable task of scaling back our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had provided more than $1.9bn in health funding to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has called for more talks to secure a agreement acceptable to all parties so the nation's critical HIV programme can be sustained.

Wider Implications

This development follows a comparable situation in neighbouring Kenya, where a court blocked a similar health funding agreement after concerns were filed about the security of Kenyans' medical information.

After returning to office recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).

The agency had administered aid for the American government, but Trump claimed its expenditure was "inefficient" and his government was pursuing government-to-government agreements to enhance openness and accountability.

Based on reports, 16 African countries have so far signed these new agreements, representing more than $18.3bn of fresh investment.

Details of the Rejected Agreement

This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this partnership could have provided immense benefits for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy through US-supported programmes," the Ambassador added.

However, official spokesman Nick Mangwana maintained the arrangement was "unfair".

"The proposal required Zimbabwe to share its genetic material and health information indefinitely, with no corresponding assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.

"Effectively, our nation would supply the basic resources for medical research without any assurance that the resulting innovations would be accessible to our people if a new disease outbreak emerge."

Sovereignty and Global Health

Mangwana further pointed out that the American exit from the global health body and its pursuit of bilateral deals were undermining frameworks already set up through the international health agency.

Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to manage future pandemics.

"This system is designed to guarantee that when a country contributes its samples, the benefits – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the resources to develop them."

The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.

"We encourage further discussions with our American counterparts on how subsequent collaboration could be arranged in a manner that honours the sovereignty and interests of both nations."

Health Experts Response

Medical experts said it recognised the government's concerns, but suggested that talks should continue considering much of the country's Aids initiatives depended on external financing.

"If specific concerns exist, such as those relating to data governance or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," the group said.

The situation highlights the complex tensions between accepting crucial international aid and safeguarding a country's data in an increasingly data-driven world.

The writer

Matthew Smith

A seasoned journalist specializing in global affairs and digital media trends, with over a decade of experience in international reporting.

Trend Global Media

Type to search articles.